Vincere is developing small molecules that increase mitophagy with a focus on USP30 inhibitors with potential for Parkinson's disease, cardio-renal indications, and other age-related disease.
Address
CambridgeMassachusetts
United States
Vincere is developing small molecules that increase mitophagy with a focus on USP30 inhibitors with potential for Parkinson's disease, cardio-renal indications, and other age-related disease.